Liu H, Xu H, Chi P, Feng Z, et al. A prophylactic tyrosine kinase inhibitor strategy based on measurable residual disease pre-transplantation for Ph(+) acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation: A prospective multicenter cohort study. Am J Hematol 2024 Nov 16. doi: 10.1002/ajh.27516.
PMID: 39548804